BiVictriX Therapeutics
Manufacturing · United Kingdom · 1-10 Employees
View Company Info for Free
Overview
Headquarters
Mereside Alderley Park, Alderley Park, C...Website
www.bivictrix.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About BiVictriX Therapeutics
BiVictriX Therapeutics is focused on revolutionizing cancer therapy by developing next-generation therapeutics that selectively target cancer cells while sparing healthy cells. Utilizing their proprietary Bi-Cygni approach, they create Antibody Drug-Conjugates (ADCs) that combine the targeting capabilities of antibodies with potent chemotherapy agents. Their mission is to ensure that effective cancer treatments are accessible to all patients, particularly those with aggressive cancers. The company aims to enhance the effectiveness of therapies while minimizing harm to patients, making them a key player in the oncology field.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is BiVictriX Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when BiVictriX Therapeutics launches new products
Click to see if BiVictriX Therapeutics had a recent Job posting/layoffs
Check out if BiVictriX Therapeutics is spiking on competitors!
Website visits: Recent activity has been detected on your website
BiVictriX Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Check if BiVictriX Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once BiVictriX Therapeutics has new funding data
Congratulate Masked Content for being promoted to Masked Content at BiVictriX Therapeutics
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on BiVictriX Therapeutics recently announced quarterly report
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to BiVictriX Therapeutics
Compare insights from companies similar to BiVictriX Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Company Profile Activity
Activity Insights
BiVictriX Therapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
BiVictriX Therapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about BiVictriX Therapeutics.
BiVictriX Therapeutics financials insights
Gather financial insights about BiVictriX Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2017
Angel/Seed
$533K
BiVictriX Therapeutics Tech Stack
A closer look at the technologies used by BiVictriX Therapeutics
Most Recent Scoops
Event
Events, Engineering, Sales, Bioengineering, Laboratory Operations, Pharmaceuticals, Field /Outside Sales, Clinical Operations, Field Marketing, Operations
Person-Based
Left Company
Executive Move
New Hire
Executive Move
New Hire
Executive Move
BiVictriX Therapeutics News & Media
Market Sentiment Around Loss-Making BiVictriX Therapeutics Plc (LON:BVX)
With the business potentially at an important milestone, we thought we'd take a closer look at BiVictriX Therapeutics...IN BRIEF: BiVictrix Therapeutics appoints Inflazome director as CFO | Financial News
IN BRIEF: BiVictrix Therapeutics appoints Inflazome director as CFO | Financial NewsThe Welsh firms raising equity to expand and create new jobs
Firms raising equity include Coincover, Reacta, Space Forge and BiVictriX Therapeutics and Riversimple
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding BiVictriX Therapeutics
Sign Up For FreeTo access detailed company insights
BiVictriX Therapeutics is focused on revolutionizing cancer therapy by developing next-generation therapeutics that selectively target cancer cells while sparing healthy cells. Utilizing their proprietary Bi-Cygni approach, they create Antibody Drug-Conjugates (ADCs) that combine the targeting capabilities of antibodies with potent chemotherapy age... Read More
